AR022906A1 - Amidas de aminoacidos modificadas, medicamentos que contienen estos compuestos y procedimiento para su preparacion - Google Patents
Amidas de aminoacidos modificadas, medicamentos que contienen estos compuestos y procedimiento para su preparacionInfo
- Publication number
- AR022906A1 AR022906A1 ARP000101081A ARP000101081A AR022906A1 AR 022906 A1 AR022906 A1 AR 022906A1 AR P000101081 A ARP000101081 A AR P000101081A AR P000101081 A ARP000101081 A AR P000101081A AR 022906 A1 AR022906 A1 AR 022906A1
- Authority
- AR
- Argentina
- Prior art keywords
- compounds
- procedure
- modified amino
- amidas
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Diabetes (AREA)
- Neurology (AREA)
- Endocrinology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Neurosurgery (AREA)
- Dermatology (AREA)
- Biochemistry (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Rheumatology (AREA)
- Reproductive Health (AREA)
- Immunology (AREA)
- Emergency Medicine (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Amidas de aminoácidos modificadas de la formula general (1) en la que A, R, R1, R2, X1, X2, X3 e Y están definidos como en la reivindicacion 1, sustautomeros, sus diastereoisomeros, sus enantiomeros, sus mezclas y sus sales, en particular sus sales fisiologicamente compatibles con ácidos o basesinorgánicos u orgánicos, que presentan efectos antagonistas de CGRP, medicamentos que contienen estos compuestos, su empleo y procedimiento para supreparacion, así como su empleo para la produccion y purificacion de anticuerpos y como compuestos marcados en ensayos RIA y ELISA o como coadyuvantesdiagnosticos y analíticos en la investigacion de neurotransmisores.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19911039A DE19911039A1 (de) | 1999-03-12 | 1999-03-12 | Abgewandelte Aminosäureamide, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung |
Publications (1)
Publication Number | Publication Date |
---|---|
AR022906A1 true AR022906A1 (es) | 2002-09-04 |
Family
ID=7900727
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP000101081A Pending AR022906A1 (es) | 1999-03-12 | 2000-03-10 | Amidas de aminoacidos modificadas, medicamentos que contienen estos compuestos y procedimiento para su preparacion |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP1163239B1 (es) |
JP (1) | JP3719937B2 (es) |
AR (1) | AR022906A1 (es) |
AT (1) | ATE241616T1 (es) |
AU (1) | AU4288000A (es) |
CA (1) | CA2361939A1 (es) |
CO (1) | CO5150226A1 (es) |
DE (2) | DE19911039A1 (es) |
DK (1) | DK1163239T3 (es) |
ES (1) | ES2199819T3 (es) |
PT (1) | PT1163239E (es) |
UY (1) | UY26057A1 (es) |
WO (1) | WO2000055154A1 (es) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19937304C2 (de) * | 1999-08-10 | 2003-08-21 | Boehringer Ingelheim Pharma | Verwendung von CGRP-Antagonisten zur Bekämpfung menopausaler Hitzewallungen |
US6521609B1 (en) | 1999-08-10 | 2003-02-18 | Boehringer Ingelheim Pharma Kg | Use of CGRP antagonists and CGRP release inhibitors for combating menopausal hot flushes |
DE19952147A1 (de) | 1999-10-29 | 2001-05-03 | Boehringer Ingelheim Pharma | Neue Cyclopropane, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung |
EP1456198A1 (en) | 2001-12-12 | 2004-09-15 | Eli Lilly And Company | Alanyl-piperidine heterocyclic derivatives useful against cardiovascular diseases |
GB0211649D0 (en) | 2002-05-21 | 2002-07-03 | Novartis Ag | Organic compounds |
US7220862B2 (en) | 2002-06-05 | 2007-05-22 | Bristol-Myers Squibb Company | Calcitonin gene related peptide receptor antagonists |
MXPA04011960A (es) | 2002-06-05 | 2005-03-31 | Squibb Bristol Myers Co | Antagonistas de receptores de peptidos relacionados con el gen de calcitonina. |
US7842808B2 (en) | 2002-06-05 | 2010-11-30 | Bristol-Myers Squibb Company | Anti-migraine spirocycles |
DE10227294A1 (de) * | 2002-06-19 | 2004-01-08 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Zubereitungen zur intranasalen Applikation ausgewählter, von Aminosäuren abgeleiteter CGRP-Antagonisten sowie Verfahren zu deren Herstellung |
DE60326370D1 (de) | 2002-08-12 | 2009-04-09 | Actavis Group Hf | Verwendung von cgrp-antagonisten-verbindungen zur behandlung von psoriasis |
US11517612B2 (en) | 2016-11-18 | 2022-12-06 | Nepsone Ehf | Methods of treating inflammatory skin disorders |
US7595312B2 (en) | 2002-10-25 | 2009-09-29 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions |
DE10250082A1 (de) * | 2002-10-25 | 2004-05-13 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Ausgewählte CGRP-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel |
CN100558428C (zh) | 2003-12-05 | 2009-11-11 | 布里斯托尔-迈尔斯·斯奎布公司 | 降钙素基因相关肽受体拮抗剂 |
AR046787A1 (es) | 2003-12-05 | 2005-12-21 | Bristol Myers Squibb Co | Agentes antimigrana heterociclicos |
DE102004006893A1 (de) * | 2004-02-12 | 2005-09-01 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verfahren zur Herstellung von 1[N2-[3,5-Dibrom-N-[[4-(3,4-dihydro-2(1H)-oxochinazolin-3-yl)-1-piperidinyl]carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyridinyl)-piperazin |
DE102004015723A1 (de) | 2004-03-29 | 2005-10-20 | Boehringer Ingelheim Pharma | Ausgewählte CGRP-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel |
TW200533398A (en) | 2004-03-29 | 2005-10-16 | Bristol Myers Squibb Co | Novel therapeutic agents for the treatment of migraine |
EP1740175A1 (de) * | 2004-04-20 | 2007-01-10 | Boehringer Ingelheim International Gmbh | Verwendung eines cgrp-antagonisten in kombination mit einem serotonin-wiederaufnahme-hemmer zur behandlung von migräne |
EP1619187A1 (de) * | 2004-07-23 | 2006-01-25 | Boehringer Ingelheim Pharma GmbH & Co. KG | Verfahren zur Herstellung von 3-(4-Piperidinyl)- 2,3,4,5-tetrahydro-1,3-benzodiazepin-2(1H)-on |
US7384930B2 (en) | 2004-11-03 | 2008-06-10 | Bristol-Myers Squibb Company | Constrained compounds as CGRP-receptor antagonists |
US7384931B2 (en) | 2004-11-03 | 2008-06-10 | Bristol-Myers Squibb Company | Constrained compounds as CGRP-receptor antagonists |
US7449586B2 (en) | 2004-12-03 | 2008-11-11 | Bristol-Myers Squibb Company | Processes for the preparation of CGRP-receptor antagonists and intermediates thereof |
US7491717B2 (en) | 2005-03-23 | 2009-02-17 | Boehringer Ingelheim International Gmbh | Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions |
US7834007B2 (en) | 2005-08-25 | 2010-11-16 | Bristol-Myers Squibb Company | CGRP antagonists |
US7473778B2 (en) | 2005-12-24 | 2009-01-06 | Boehringer Ingelheim International Gmbh | 3-(4-piperidinyl)-2,3,4,5-tetrahydro-1,3-benzodiazepin-2(1H)-one |
EP2065381A1 (de) | 2007-10-18 | 2009-06-03 | Boehringer Ingelheim Pharma GmbH & Co. KG | CGRP Antagonisten |
NZ585347A (en) | 2007-10-18 | 2011-09-30 | Boehringer Ingelheim Int | Cgrp antagonists |
EP2251338A3 (de) | 2007-11-22 | 2011-06-08 | Boehringer Ingelheim International GmbH | Organische Verbindungen |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0927192B1 (de) * | 1996-09-10 | 2004-05-12 | Boehringer Ingelheim Pharma GmbH & Co.KG | Abgewandelte aminosäuren, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
AU6211499A (en) * | 1998-09-30 | 2000-04-17 | Merck & Co., Inc. | Benzimidazolinyl piperidines as cgrp ligands |
-
1999
- 1999-03-12 DE DE19911039A patent/DE19911039A1/de not_active Withdrawn
-
2000
- 2000-03-08 DE DE50002364T patent/DE50002364D1/de not_active Expired - Fee Related
- 2000-03-08 PT PT00922505T patent/PT1163239E/pt unknown
- 2000-03-08 EP EP00922505A patent/EP1163239B1/de not_active Expired - Lifetime
- 2000-03-08 ES ES00922505T patent/ES2199819T3/es not_active Expired - Lifetime
- 2000-03-08 AU AU42880/00A patent/AU4288000A/en not_active Abandoned
- 2000-03-08 AT AT00922505T patent/ATE241616T1/de not_active IP Right Cessation
- 2000-03-08 JP JP2000605583A patent/JP3719937B2/ja not_active Expired - Fee Related
- 2000-03-08 WO PCT/EP2000/002004 patent/WO2000055154A1/de active IP Right Grant
- 2000-03-08 CA CA002361939A patent/CA2361939A1/en not_active Abandoned
- 2000-03-08 DK DK00922505T patent/DK1163239T3/da active
- 2000-03-09 CO CO00017331A patent/CO5150226A1/es unknown
- 2000-03-10 AR ARP000101081A patent/AR022906A1/es active Pending
- 2000-03-10 UY UY26057A patent/UY26057A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
EP1163239B1 (de) | 2003-05-28 |
DK1163239T3 (da) | 2003-09-08 |
JP3719937B2 (ja) | 2005-11-24 |
JP2002539208A (ja) | 2002-11-19 |
PT1163239E (pt) | 2003-10-31 |
DE50002364D1 (de) | 2003-07-03 |
ES2199819T3 (es) | 2004-03-01 |
WO2000055154A1 (de) | 2000-09-21 |
DE19911039A1 (de) | 2000-09-14 |
ATE241616T1 (de) | 2003-06-15 |
UY26057A1 (es) | 2000-10-31 |
AU4288000A (en) | 2000-10-04 |
CA2361939A1 (en) | 2000-09-21 |
CO5150226A1 (es) | 2002-04-29 |
EP1163239A1 (de) | 2001-12-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR022906A1 (es) | Amidas de aminoacidos modificadas, medicamentos que contienen estos compuestos y procedimiento para su preparacion | |
ECSP055747A (es) | Antagonistas de cgrp elegidos, procedimiento para su preparación, así como su empleo como medicamentos | |
ECSP055746A (es) | Antagonistas de cgrp elegidos, procedimiento para su preparación, así como su empleo como medicamentos | |
UY26513A1 (es) | Nuevas piperidinas sustituidas, medicamentos que contienen estos compuestos y procedimiento para su preparación. | |
MX9305566A (es) | Derivados de urea ciclicos, medicamentos que contienen estos compuestos y procedimientos para su preparacion. | |
UY29437A1 (es) | Nuevos antagonistas de cgrp | |
ECSP055910A (es) | Nuevos acidos carboxilicos y sus esteres, medicamentos que contienen estos compuestos y procedimientos para su preparacion | |
BR9909565A (pt) | Derivados bicìclicos do ácido hidroxâmico | |
BR9712023A (pt) | Aminoácidos derivados, medicamentos contendo esses compostos e processos para a sua preparação. | |
ES2088915T3 (es) | Bencimidazoles, medicamentos que contienen estos compuestos y procedimiento para su preparacion. | |
PA8592001A1 (es) | Activadores de glocoquinasa heteroaromaticos de seis miembros 5-sustituidos | |
NO920320D0 (no) | Bifenylderivater, legemidler inneholdende disse, og fremgangsmaate for deres fremstilling | |
ID21897A (id) | Asam b-sulfonil hidroksamat sebagai bahan penghambat matriks metaloproteinase | |
TR200201168T2 (tr) | CGRP-Antagonistleri-yeni siklopropanlar içeren ilaçlar ve üretim yöntemleri. | |
SE0400043D0 (sv) | New compounds | |
DE60233251D1 (de) | 4,4-difluor-1,2,3,4-tetrahydro-5h-1-benzazepinderivate und deren salze | |
BR9909739A (pt) | Benzotiadiazóis e derivados | |
BRPI0411800A (pt) | candidatos a fármacos e métodos para sua preparação | |
BRPI0406824A (pt) | Indolonaoxazoldinonas antiibacterianas, intermediários para seu preparo e composições farmacêuticas que as contêm | |
BR9713207A (pt) | Derivados de 3-mercaptoacetilamino-1,5-substituìdo-2-oxo-azepan uteis como inibidores de metaloproteinase de matriz | |
BR9603179A (pt) | Guanididas de ácido cinâmico substituìdas, processo para sua preparação, sua aplicação como medicamento ou diagnóstico, bem como medicamento que as contém | |
BR9812773A (pt) | "alfa-amino-epsilon-caprolactamas policìclicas e compostos relacionados" | |
UY26988A1 (es) | Nuevas indolinonas sustituidas, su preparación y su utilización como medicamentos. | |
ATE250021T1 (de) | Hydroxycyclopentanone | |
TNSN03118A1 (fr) | Nouveaux derives de piperidinecarboxamide, un procede pour leur preparation et les compositions pharmaceutiques les contenant |